AMENDMENT TO LICENSE AGREEMENT (Gene Sequencing)License Agreement • April 8th, 1997 • Pharmagenics Inc /De/ • Pharmaceutical preparations • Maryland
WASHINGTON, D.C. PHARMAGENICS, INC. Exhibit 10.62Letter Agreement • November 13th, 1996 • Pharmagenics Inc /De/ • Pharmaceutical preparations • New Jersey
Washington, D.C.Registration Rights Agreement • November 13th, 1996 • Pharmagenics Inc /De/ • Pharmaceutical preparations • New Jersey
AGREEMENT AND PLAN OF MERGER BETWEEN GENZYME CORPORATION AND PHARMAGENICS, INC. _____________________________ Dated as of January 31, 1997 _____________________________Agreement and Plan of Merger • February 18th, 1997 • Pharmagenics Inc /De/ • Pharmaceutical preparations • Delaware
BACKGROUNDAmendment and Agreement • April 8th, 1997 • Pharmagenics Inc /De/ • Pharmaceutical preparations • Delaware
LETTERHEAD] January 10, 1997 Confidential PharmaGenics, Inc. 4 Pearl Court Allendale, NJ 07401 Attention: Michael I. Sherman, Ph.D. Gentlemen: PaineWebber Incorporated ("PaineWebber") is pleased to act as exclusive financial advisor to PharmaGenics,...Pharmagenics Inc /De/ • April 8th, 1997 • Pharmaceutical preparations
PaineWebber Incorporated ("PaineWebber") is pleased to act as exclusive financial advisor to PharmaGenics, Inc. (the "Company") and its affiliates in connection with any proposed sale transaction involving the Company and another party (a "Purchaser"), including Genzyme Corporation or any of its subsidiaries or affiliates ("Genzyme"). This Agreement supersedes in its entirety the engagement letter dated August 15, 1996. This Agreement confirms the terms of our engagement.
